Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cancer Research and Clinical Oncology|September 15, 2022
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinomaCiro Franzese, Beatrice Marini, Davide Baldaccini, et al.Current Oncology (Toronto, Ont.)|July 25, 2022
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive RadiotherapyMaria Massaro, Davide Franceschini, Ruggero Spoto, et al.Clinical Lung Cancer|November 1, 2025
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC StudyAlessio Bruni, Davide Franceschini, Beatrice Marini, et al.La Radiologia Medica|August 31, 2024
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC studyValerio Nardone, Alessio Bruni, Davide Franceschini, et al.Cancers|September 14, 2024
Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR)Ciro Franzese, Veronica Vernier, Marco Badalamenti, et al.Radiation Oncology (London, England)|May 14, 2026
Adjuvant stereotactic pancreatic radiotherapy (SPARTA trial): interim safety analysis of an ongoing phase II single center prospective studyMaria Massaro, Tiziana Comito, Ciro Franzese, et al.Pageof 2